Publicacións nas que colabora con Pablo Romero Sanchíz (12)

2021

  1. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants

    Neuropharmacology, Vol. 149, pp. 212-220

2017

  1. Comorbilidad psiquiátrica y valores plasmáticos de 2-acilgliceroles en consumidores de alcohol en tratamiento ambulatorio. Análisis de las diferencias de género

    Adicciones: Revista de socidrogalcohol, Vol. 29, Núm. 2, pp. 83-96

  2. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders

    PLoS ONE, Vol. 12, Núm. 11

  3. Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service

    Journal of Psychoactive Drugs, Vol. 49, Núm. 4, pp. 306-315

  4. Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (tgfα) as a potential biomarker of consumption and dual diagnosis

    PeerJ, Vol. 2017, Núm. 10

  5. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity

    Frontiers in Psychiatry, Vol. 7, Núm. JAN

  6. Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence

    Addiction Biology, Vol. 22, Núm. 5, pp. 1366-1377

2015

  1. Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity

    PLoS ONE, Vol. 10, Núm. 3

  2. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: Influence of cocaine symptom severity and psychiatric co-morbidity

    Addiction Biology, Vol. 20, Núm. 4, pp. 756-772

  3. Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings

    Frontiers in Psychiatry, Vol. 6, Núm. FEB